Seventy-three percent of U.S. commercial health insurance markets are highly concentrated based on guidelines used by the Department of Justice and Federal Trade Commission to assess market competition, according to the latest annual report on health insurance competition by the American Medical Association. In 91% of the 384 metropolitan statistical areas studied, at least one insurer had a commercial market share of 30% or more, and in 46% of MSAs a single insurer’s share was at least 50%. Fifty-four percent of markets that were highly concentrated in 2014 became even more concentrated by 2020, the study found.

“These markets are ripe for the exercise of health insurer market power, which harms consumers and providers of care,” the report concludes. “Our findings should prompt federal and state antitrust authorities to vigorously examine the competitive effects of proposed mergers involving health insurers.”

The findings are based on data on commercial enrollment in preferred provider organization, health maintenance organization, point-of-service, exchange and consumer-driven health plans.

 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services has launched a new webpage with resources and guidance related to the dispute resolution process under the No…
Headline
The Centers for Medicare & Medicaid Services today approved state plan amendments allowing Hawaii, Maryland and Ohio to extend postpartum coverage…
Headline
Some commercial insurer policies may hurt patients, contribute to clinician burnout and drive up the cost of care, AHA President and CEO Rick Pollack notes in…
Headline
The Senate this weekend is expected to take up the Inflation Reduction Act (H.R. 5376), the latest version of the Build Back Better Act, a roughly $700 billion…
Headline
A trial in a federal lawsuit  to stop UnitedHealth Group from acquiring Change Healthcare kicked off today in the U.S. District Court for the District of…
Perspective
Delaying and denying authorizations for medically necessary care. Forcing patients to try potentially ineffective treatments through step therapy, or “fail…